Bernini F, Tanenbaum S R, Sherrill B C, Gotto A M, Smith L C
J Biol Chem. 1986 Jul 15;261(20):9294-9.
Proteins conjugated with lactose residues exhibit enhanced hepatic uptake mediated by the galactose receptor. In this study, we demonstrate that lactosaminated Fab fragments (lac-Fab) of IgG can induce hepatic catabolism of specific antigens, especially low density lipoproteins (LDL). lac-Fab and human LDL-lac-Fab complex exhibited specific uptake in isolated rat hepatocytes. In vivo in the rat, lactosamination enhanced plasma clearance of Fab fragments 2-fold and hepatic localization 20-fold. Fab fragments retained their affinity after lactosamination. Hepatic uptake of rat 125I-IgG complexed in vitro with anti-rat lac-Fab was increased almost 5-fold, compared to rat 125I-IgG alone. Injection of rats with anti-LDL lac-Fab induced plasma clearance and hepatic uptake of tracer amounts of previously injected human 125I-LDL, which decreased 50% 10 min after injection of lac-Fab, with 30% present in the liver. Asialofetuin completely inhibited these processes. After a bolus of 6 mg of human LDL, administration of anti-LDL lac-Fab reduced the serum cholesterol of rats to basal values within 2.5 h. These findings suggest that lactosaminated Fab fragments of specific IgGs are effective reagents for inducing hepatic uptake of macromolecules through the galactose receptor. lac-Fab specific for LDL may be an effective hypocholesterolemic agent in vivo.
与乳糖残基结合的蛋白质表现出由半乳糖受体介导的肝脏摄取增强。在本研究中,我们证明了IgG的乳糖胺化Fab片段(lac-Fab)可以诱导特定抗原,尤其是低密度脂蛋白(LDL)的肝脏分解代谢。lac-Fab和人LDL-lac-Fab复合物在分离的大鼠肝细胞中表现出特异性摄取。在大鼠体内,乳糖胺化使Fab片段的血浆清除率提高了2倍,肝脏定位提高了20倍。乳糖胺化后Fab片段保留了其亲和力。与单独的大鼠125I-IgG相比,体外与抗大鼠lac-Fab复合的大鼠125I-IgG的肝脏摄取增加了近5倍。给大鼠注射抗LDL lac-Fab可诱导先前注射的微量人125I-LDL的血浆清除和肝脏摄取,注射lac-Fab后10分钟,其含量降低了50%,30%存在于肝脏中。去唾液酸胎球蛋白完全抑制了这些过程。在静脉注射6mg人LDL后,给予抗LDL lac-Fab可在2.5小时内将大鼠血清胆固醇降至基础值。这些发现表明,特定IgG的乳糖胺化Fab片段是通过半乳糖受体诱导大分子肝脏摄取的有效试剂。对LDL具有特异性的lac-Fab在体内可能是一种有效的降胆固醇药物。